Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats
Toxicologic Pathology · 2023
DOI: 10.1177/01926233231162809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, 2023. Verfasst von Yi-Zhong Gu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., West Point, Pennsylvania, USA. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Activating mutations of the leucine-rich repeat kinase 2 ( LRRK2) gene are associated with Parkinson disease (PD), prompting development of LRRK2 inhibitors as potential treatment for PD. However, kidney safety concerns have surfaced from LRRK2 knockout (KO) mice and rats and from repeat-dose studies in rodents administered LRRK2 inhibitors. To support drug development of this therapeutic target, we conducted a study of 26 weeks’ duration in 2-month-old wild-type and LRRK2 KO Long-Evans Hooded rats to systematically examine the performance of urinary safety biomarkers and to characterize the nature of the morphological changes in the kidneys by light microscopy and by ultrastructural evaluation. Our data reveal the time course of early-onset albuminuria at 3 and 4 months in LRRK2 KO female and male rats, respectively. The increases in urine albumin were not accompanied by concurrent increases in serum creatinine, blood urea nitrogen, or renal safety biomarkers such as kidney injury molecule 1 or clusterin, although morphological alterations in both glomerular and tubular structure were identified by light and transmission electron microscopy at 8 months of age. Diet optimization with controlled food intake attenuated the progression of albuminuria and associated renal changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merck & Co., Inc., West Point, Pennsylvania, USA.
ORCID-Profile: Yi-Zhong Gu, Katerina Vlasakova, Nicholas T Gatto
Zitieren
APA
Gu, Y. Z., Vlasakova, K., Miller, G., Gatto, N. T., Ciaccio, P. J., Kuruvilla, S., Besteman, E. G., Smith, R., Reynolds, S. J., Amin, R. P., Glaab, W. E., Wollenberg, G., Lebron, J., & Sistare, F. D. (2023). Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats. Toxicologic Pathology. https://doi.org/10.1177/01926233231162809
Vancouver
Gu YZ, Vlasakova K, Miller G, Gatto NT, Ciaccio PJ, Kuruvilla S, et al. Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats. Toxicologic Pathology. 2023. doi:10.1177/01926233231162809
BibTeX
@article{Gu2023,
author = {Gu, Yi-Zhong and Vlasakova, Katerina and Miller, Glen and Gatto, Nicholas T and Ciaccio, Paul J and Kuruvilla, Sabu and Besteman, Elizabeth G and Smith, Roger and Reynolds, Spencer J and Amin, Rupesh P and Glaab, Warren E and Wollenberg, Gordon and Lebron, Jose and Sistare, Frank D},
title = {Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats},
journal = {Toxicologic Pathology},
year = {2023},
doi = {10.1177/01926233231162809}
}
EUVIMED